We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.9B
AUM Growth
+$433M
Cap. Flow
+$143M
Cap. Flow %
1.31%
Top 10 Hldgs %
18.12%
Holding
2,433
New
160
Increased
1,129
Reduced
851
Closed
234
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCF
1751
DELISTED
TCF Financial Corporation Common Stock
TCF
$300K ﹤0.01%
7,304
-659
-8% -$27.3K
NCZ
1752
Virtus Convertible & Income Fund II
NCZ
$304M
$297K ﹤0.01%
14,703
+3,721
+34% +$76.2K
IGE icon
1753
iShares North American Natural Resources ETF
IGE
$784M
$295K ﹤0.01%
9,615
-1,823
-16% -$55.7K
LYG icon
1754
Lloyds Banking Group
LYG
$88.5B
$295K ﹤0.01%
103,758
+39,293
+61% +$121K
BFAM icon
1755
Bright Horizons
BFAM
$3.76B
$294K ﹤0.01%
1,951
+236
+14% +$31.6K
DHC
1756
Diversified Healthcare Trust
DHC
$1.98B
$294K ﹤0.01%
35,538
-5,644
-14% -$47K
EPI icon
1757
WisdomTree India Earnings Fund ETF
EPI
$2.05B
$294K ﹤0.01%
11,288
+59
+0.5% +$1.53K
FC icon
1758
Franklin Covey
FC
$235M
$294K ﹤0.01%
+8,658
New +$257K
CPF icon
1759
Central Pacific Financial
CPF
$996M
$292K ﹤0.01%
9,754
IFGL icon
1760
iShares International Developed Real Estate ETF
IFGL
$82.2M
$291K ﹤0.01%
9,752
+1,678
+21% +$50.1K
PLAY icon
1761
Dave & Buster's
PLAY
$349M
$291K ﹤0.01%
+7,201
New +$366K
TEVA icon
1762
Teva Pharmaceuticals
TEVA
$42.5B
$290K ﹤0.01%
31,412
-1,065
-3% -$12.8K
CCOI icon
1763
Cogent Communications
CCOI
$554M
$289K ﹤0.01%
4,860
+822
+20% +$47.2K
FPI
1764
Farmland Partners
FPI
$425M
$288K ﹤0.01%
40,893
+223
+0.5% +$1.45K
KRG icon
1765
Kite Realty
KRG
$5.24B
$287K ﹤0.01%
18,973
-457
-2% -$7.22K
SUN icon
1766
Sunoco
SUN
$13.8B
$287K ﹤0.01%
+9,180
New +$282K
LPT
1767
DELISTED
Liberty Property Trust
LPT
$287K ﹤0.01%
5,731
+405
+8% +$19.8K
DEI icon
1768
Douglas Emmett
DEI
$1.92B
$286K ﹤0.01%
7,183
+70
+1% +$2.87K
ERII icon
1769
Energy Recovery
ERII
$394M
$286K ﹤0.01%
27,417
+7,360
+37% +$72.4K
OSK icon
1770
Oshkosh
OSK
$9.62B
$286K ﹤0.01%
3,430
-9,682
-74% -$762K
XMPT icon
1771
VanEck CEF Muni Income ETF
XMPT
$220M
$286K ﹤0.01%
10,598
+145
+1% +$3.82K
JBSS icon
1772
John B. Sanfilippo & Son
JBSS
$978M
$284K ﹤0.01%
3,566
+66
+2% +$5.01K
WSBC icon
1773
WesBanco
WSBC
$4.05B
$282K ﹤0.01%
7,303
+128
+2% +$4.93K
AXSM icon
1774
Axsome Therapeutics
AXSM
$11.3B
$281K ﹤0.01%
+10,900
New +$218K
EHTH icon
1775
eHealth
EHTH
$39.1M
$281K ﹤0.01%
+3,262
New +$220K

Similar funds

Cambridge Investment Research Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Cambridge Investment Research Advisors held 2,433 positions worth $10.9B, up 4.1% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2019 filing shows 160 new, 1,129 increased, 851 reduced and 234 closed positions. Its largest new stake was WisdomTree International ESG Fund: 441,613 shares worth $10.6M. The largest sale was Vanguard S&P 500 ETF, an estimated $38M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2019 buy was WisdomTree International ESG Fund: 441,613 shares worth $10.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2019, an estimated $27M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $38M.
  • Cambridge Investment Research Advisors fully exited DuPont de Nemours in Q2 2019, selling an estimated $17.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $10.9B portfolio in Q2 2019.
  • Cambridge Investment Research Advisors opened 160 new positions and closed 234 in Q2 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $10.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.